# Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora

> **NCT01282541** · PHASE2 · COMPLETED · sponsor: **Merbs, Shannath, M.D., Ph.D.** · enrollment: 26 (actual)

## Conditions studied

- Epiphora

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT01282541
- **Lead sponsor:** Merbs, Shannath, M.D., Ph.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282541, "Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01282541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*